Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
106
-
Total 13F shares, excl. options
-
119M
-
Shares change
-
+15.2M
-
Total reported value, excl. options
-
$236M
-
Value change
-
+$30.4M
-
Put/Call ratio
-
0.68
-
Number of buys
-
61
-
Number of sells
-
-51
-
Price
-
$1.98
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q2 2022
137 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q2 2022.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 119M shares
of 237M outstanding shares and own 50.34% of the company stock.
Largest 10 shareholders include BlackRock Inc. (12.6M shares), PERCEPTIVE ADVISORS LLC (11.5M shares), BOOTHBAY FUND MANAGEMENT, LLC (10.4M shares), VANGUARD GROUP INC (9.04M shares), Nuveen Asset Management, LLC (7.16M shares), Stonepine Capital Management, LLC (7M shares), Magnetar Financial LLC (6.86M shares), Velan Capital Investment Management LP (6.07M shares), MILLENNIUM MANAGEMENT LLC (5.89M shares), and AWM Investment Company, Inc. (5.02M shares).
This table shows the top 106 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.